Compounds > arsenic trisulfide
Page last updated: 2024-08-24

arsenic trisulfide and Acute Promyelocytic Leukemia

arsenic trisulfide has been researched along with Acute Promyelocytic Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, X; Jia, Y; Liu, Y; Zhang, M1
Cheng, X; He, P; Liu, F; Liu, Y; Shi, L; Tian, Y; Wang, Y; Zhang, M; Zhao, J; Zhou, N; Zhu, H1
Cheng, X; He, P; Liu, Y; Qi, J; Wang, C; Wang, Y; Zhang, M; Zhao, J; Zhu, H1
Bao, L; Huang, XJ; Jiang, B; Jiang, H; Jiang, Q; Lin, W; Liu, YR; Lu, J; Lu, XJ; Zhang, Y1
Gou, BD; Huang, J; Luo, LY; Wang, K; Zhang, TL1

Other Studies

5 other study(ies) available for arsenic trisulfide and Acute Promyelocytic Leukemia

ArticleYear
Tetra-arsenic tetra-sulfide enhances NK-92MI mediated cellular immunotherapy in all-trans retinoic acid-resistant acute promyelocytic leukemia.
    Investigational new drugs, 2022, Volume: 40, Issue:6

    Topics: Animals; Arsenic; Arsenicals; Immunotherapy; Leukemia, Promyelocytic, Acute; Mice; Oxides; Sulfides; Tretinoin; Tumor Microenvironment

2022
Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Apoptosis; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Shape; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Chaperones; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Protein Phosphatase 2; Proteome; Proteomics; Retinoids; RNA, Messenger; RNA, Small Interfering; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfides; Transcription Factors

2014
Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide.
    International journal of oncology, 2015, Volume: 47, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Blotting, Western; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Gene Knockdown Techniques; Humans; Leukemia, Promyelocytic, Acute; Prohibitins; Real-Time Polymerase Chain Reaction; Repressor Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfides; Tandem Mass Spectrometry; Transfection

2015
[Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
    Zhonghua yi xue za zhi, 2008, Aug-19, Volume: 88, Issue:32

    Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Chromosome Aberrations; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Retrospective Studies; Sulfides; Treatment Outcome; Tretinoin; Young Adult

2008
Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by arsenic sulphide: involvement of serine/threonine protein phosphatases.
    Leukemia research, 2006, Volume: 30, Issue:11

    Topics: Arsenicals; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Monocytes; Phosphoprotein Phosphatases; Serine; Structure-Activity Relationship; Sulfides; Threonine

2006